Wilbanks Smith & Thomas Asset Management LLC Kodiak Sciences Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 05, 2022	SELL	$7.09 - $89.45 $21,255 - $268,171	-2,998 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$81.97 - $106.94 $245,746 - $320,606	2,998 New	2,998 $288,000

Others Institutions Holding KOD

# of Institutions

111

Shares Held

43M

Call Options Held

87.8K

Put Options Held

7.3K

Baker Bros. Advisors LP New York, NY

17.3M
Shares

$38.8 Million
1.15% of portfolio
Black Rock Inc. New York, NY

3.86M
Shares

$8.64 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.72M
Shares

$3.86 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

1.65M
Shares

$3.71 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.61M
Shares

$3.61 Million
0.24% of portfolio

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $117M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account